Concepedia

Vittore Cereda

VC

Statistics

Publications

21

Citations

1.6K

H-Index

19

Active since

2004

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

University of Rome Tor Vergata

National Institutes of Health

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Vittore Cereda is an author at National Cancer Institute specializing in oncology, medicine, and immunology.

ORCID

Publications per year

2004–2016

21

Publications

21

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

James L. Gulley, Philip M. Arlen, Ravi A. Madan et al. · Cancer Immunology Immunotherapy · 2009 · 298 citations · Full text

, , +17

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

James L. Gulley, Philip M. Arlen, Kwong-Yok Tsang et al. · Clinical Cancer Research · 2008 · 229 citations · Full text

, , +17

Effects of conventional therapeutic interventions on the number and function of regulatory T cells

Mario Roselli, Vittore Cereda, Maria Giovanna di Bari et al. · OncoImmunology · 2013 · 186 citations · Full text

, , +17

Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer

Junko Yokokawa, Vittore Cereda, Cinzia Remondo et al. · Clinical Cancer Research · 2008 · 149 citations

, , +17

Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant

Robert J. Lechleider, Philip M. Arlen, Kwong-Yok Tsang et al. · Clinical Cancer Research · 2008 · 106 citations · Full text

, , +17

1–5 of 21